Showing results (41-50 of 153) with videos related to

Sort By:
Pageof 16
Clinical & Experimental Metastasis|October 4, 2003
Inhibition of alpha(v)beta3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastasesJeffrey A Nemeth, Michael L Cher, Zhao Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
Effect of neoadjuvant androgen deprivation on circulating prostate cells in the bone marrow of men undergoing radical prostatectomyD P Wood, A Beaman, M Banerjee, et al.
Medical Research Archives|January 19, 2024
A Novel Interaction between Chemokine and Phosphoinositide Signaling in Metastatic Prostate CancerCodrut Radoiu, Barani Govindarajan, Michael Wang, et al.
Cancer Detection and Prevention|July 15, 1999
Prospects of immunotherapy for the treatment of prostate carcinoma--a reviewG G Hillman, J A Triest, M L Cher, et al.
Molecular Cancer Research : MCR|March 14, 2008
CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in boneSreenivasa R Chinni, Hamilto Yamamoto, Zhong Dong, et al.
World Journal of Urology|January 1, 1996
Smooth-muscle myosin heavy-chain isoform expression in bladder-outlet obstructionM L Cher, B B Abernathy, J D McConnell, et al.
BJU International|April 4, 2017
Prostate cancer family history and eligibility for active surveillance: a systematic review of the literatureJaya M Telang, Brian R Lane, Michael L Cher, et al.
Research Square|March 3, 2023
Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growthBarani Govindarajan, Diego Sbrissa, Mark Pressprich, et al.
Cancer Genetics and Cytogenetics|August 16, 2000
Stepwise genetic changes associated with progression of nontumorigenic HPV-18 immortalized human prostate cancer-derived cell line to a malignant phenotypeB Hukku, M Mally, M L Cher, et al.
The Journal of Urology|May 2, 2020
Delayed Radical Prostatectomy is Not Associated with Adverse Oncologic Outcomes: Implications for Men Experiencing Surgical Delay Due to the COVID-19 PandemicKevin B Ginsburg, Gannon L Curtis, Ryan E Timar, et al.
Pageof 16